These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28819566)

  • 1. Development of Poly Lactic/Glycolic Acid (PLGA) Microspheres for Controlled Release of Rho-Associated Kinase Inhibitor.
    Koda S; Okumura N; Kitano J; Koizumi N; Tabata Y
    J Ophthalmol; 2017; 2017():1598218. PubMed ID: 28819566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
    Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
    J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid) microspheres made by the double emulsion method.
    Cui F; Cun D; Tao A; Yang M; Shi K; Zhao M; Guan Y
    J Control Release; 2005 Oct; 107(2):310-9. PubMed ID: 16255081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization.
    Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD
    Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Cleland JL; Mac A; Boyd B; Yang J; Duenas ET; Yeung D; Brooks D; Hsu C; Chu H; Mukku V; Jones AJ
    Pharm Res; 1997 Apr; 14(4):420-5. PubMed ID: 9144725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of releasing recombinant human growth and differentiation factor-5 from poly(lactic-co-glycolic acid) microspheres for repair of the rat degenerated intervertebral disc.
    Yan J; Yang S; Sun H; Guo D; Wu B; Ji F; Zhou D
    J Biomater Appl; 2014 Jul; 29(1):72-80. PubMed ID: 24327349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.
    Carrasquillo KG; Ricker JA; Rigas IK; Miller JW; Gragoudas ES; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):290-9. PubMed ID: 12506087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained release of melatonin from poly (lactic-co-glycolic acid) (PLGA) microspheres to induce osteogenesis of human mesenchymal stem cells in vitro.
    Zhang L; Zhang J; Ling Y; Chen C; Liang A; Peng Y; Chang H; Su P; Huang D
    J Pineal Res; 2013 Jan; 54(1):24-32. PubMed ID: 22712496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual-application poly (dl-lactic-co-glycolic) acid (PLGA)-chitosan composite scaffold for potential use in bone tissue engineering.
    Boukari Y; Qutachi O; Scurr DJ; Morris AP; Doughty SW; Billa N
    J Biomater Sci Polym Ed; 2017 Nov; 28(16):1966-1983. PubMed ID: 28777694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
    Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
    He JT; Tao XM; Mo W; Song HY
    Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Human Dental Pulp Cells on a Potential Injectable Poly(lactic-co-glycolic acid) Microsphere Scaffold.
    Zou H; Wang G; Song F; Shi X
    J Endod; 2017 May; 43(5):745-750. PubMed ID: 28292602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen.
    Chang AC; Gupta RK
    J Pharm Sci; 1996 Feb; 85(2):129-32. PubMed ID: 8683435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable poly(lactic-co-glycolic acid) microspheres loaded with S-nitroso-N-acetyl-D-penicillamine for controlled nitric oxide delivery.
    Lautner G; Meyerhoff ME; Schwendeman SP
    J Control Release; 2016 Mar; 225():133-9. PubMed ID: 26763376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-responsive and porous vancomycin-loaded PLGA microspheres: evidence of controlled and sustained release for localized inflammation inhibition
    Yu X; Pan Q; Zheng Z; Chen Y; Chen Y; Weng S; Huang L
    RSC Adv; 2018 Nov; 8(65):37424-37432. PubMed ID: 35557787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.